Abstract

BackgroundHIV testing uptake remains low among men in sub-Saharan Africa. HIV self-testing (HIVST) at the workplace is a novel approach to increase the availability of, and access to, testing among men. However, both access and linkage to posttest services remain a challenge.ObjectiveThe aim of this protocol is to describe a cluster randomized trial (CRT)—Workplace-Based HIV Self-testing Among Men (WISe-Men)—to evaluate the effect of HIVST in workplace settings on the uptake of HIV testing services (HTS) and linkage to treatment and prevention services among men employed in private security services in Uganda.MethodsThis is a two-arm CRT involving men employed in private security services in two Ugandan districts. The participants in the intervention clusters will undergo workplace-based HIVST using OraQuick test kits. Those in the control clusters will receive routine HTS at their work premises. In addition to HTS, participants in both the intervention and control arms will undergo other tests and assessments, which include blood pressure assessment, blood glucose and BMI measurement, and rapid diagnostic testing for syphilis. The primary outcome is the uptake of HIV testing. The secondary outcomes include HIV status reporting, linkage into HIV care and confirmatory testing following HIVST, initiation of antiretroviral therapy following a confirmatory HIV test, the uptake of voluntary medical male circumcision, consistent condom use, and the uptake of pre-exposure prophylaxis by the most at-risk populations.ResultsParticipant enrollment commenced in February 2020, and the trial is still recruiting study participants. Follow-up for currently enrolled participants is ongoing. Data collection and analysis is expected to be completed in December 2021.ConclusionsThe WISe-Men trial will provide information regarding whether self-testing at worksites increases the uptake of HIV testing as well as the linkage to care and prevention services at male-dominated workplaces in Uganda. Additionally, the findings will help us propose strategies for improving men’s engagement in HTS and ways to improve linkage to further care following a reactive or nonreactive HIVST result.Trial RegistrationClinicalTrials.gov NCT04164433; https://clinicaltrials.gov/ct2/show/NCT04164433International Registered Report Identifier (IRRID)DERR1-10.2196/25099

Highlights

  • BackgroundGlobal estimates report that 81% of people living with HIV (PLHIV) knew their HIV status at the end of 2019, and 67% were on antiretroviral therapy (ART) [1]

  • The WISe-Men trial will provide information regarding whether self-testing at worksites increases the uptake of HIV testing as well as the linkage to care and prevention services at male-dominated workplaces in Uganda

  • We propose the use of HIV self-testing (HIVST) to increase the uptake of HIV testing services (HTS) at the workplace

Read more

Summary

Introduction

BackgroundGlobal estimates report that 81% of people living with HIV (PLHIV) knew their HIV status at the end of 2019, and 67% were on antiretroviral therapy (ART) [1]. Over the past several years, there has been a significant decrease in new HIV infections and an increase in the proportion of people accessing ART, with a consequent decline in AIDS-related deaths [2]. The current level of new infections in Uganda is still remarkably high, with an estimated 53,000 newly infected people in 2019 [4] This may be an indication that the country will continue to register high numbers of people with HIV unless innovative measures are put in place to reach and test hard-to-reach populations such as men and youths [13]. HIV self-testing (HIVST) at the workplace is a novel approach to increase the availability of, and access to, testing among men Both access and linkage to posttest services remain a challenge

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call